Supriya Life Sciences, Blue Cross Laboratories and Yasho Industries are among half a dozen companies that have received fresh summons in the New Year under the GST regime.
In the last 15 days, more than 60 summons have been issued to companies across sectors including pharma, IT and chemical, multiple industry insiders said. Some of the companies have even approached courts seeking quashing of these summons. “Sending summons is part of the process,” a Central Board of Indirect Taxes and Customs (CBIC) official told ET. “In cases where it is felt that there is some anomaly that needs further explanation beyond what has been provided, summons are issued.” “The companies have time to respond to summons,” the CBIC official added.
However, some of the companies said summons have been issued to them seeking more documents. They said their top management has also been summoned even though they were willing to provide the requisite information.
The CBIC had in December asked its field formations to complete pending cases and refocus on revenue collection in the last quarter.
Supriya Life Sciences, Blue Cross Laboratories and Yasho Industries did not respond to emails seeking comment until press time.
Blue Cross Laboratories has filed a writ petition before the Bombay High Court at Goa. The matter is due for hearing on January 18.